Lyncia
2021-08-09
Great
Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
6
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":898630327,"tweetId":"898630327","gmtCreate":1628490683969,"gmtModify":1631888757130,"author":{"id":3573731744796242,"idStr":"3573731744796242","authorId":3573731744796242,"authorIdStr":"3573731744796242","name":"Lyncia","avatar":"https://static.tigerbbs.com/49f028b5d2bdd6033e8767d4ec0ff621","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":8,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Great </p></body></html>","htmlText":"<html><head></head><body><p>Great </p></body></html>","text":"Great","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/898630327","repostId":2158413272,"repostType":4,"repost":{"id":"2158413272","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1628489696,"share":"https://www.laohu8.com/m/news/2158413272?lang=&edition=full","pubTime":"2021-08-09 14:14","market":"us","language":"en","title":"Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd","url":"https://stock-news.laohu8.com/highlight/detail?id=2158413272","media":"Reuters","summary":"JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of Pfizer's COVID-19 vaccine felt","content":"<p>JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>'s COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.</p>\n<p>Israel began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.</p>\n<p>Israel's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> vaccine to more than 240,000 people.</p>\n<p>About 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.</p>\n<p>Eighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.</p>\n<p>Thirty-one percent reported some side effect, the most common being soreness at the injection site.</p>\n<p>About 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.</p>\n<p>Ran Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"</p>\n<p>\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Israeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIsraeli survey finds 3rd Pfizer vaccine dose has similar side effects to 2nd\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-09 14:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>'s COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.</p>\n<p>Israel began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.</p>\n<p>Israel's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> vaccine to more than 240,000 people.</p>\n<p>About 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.</p>\n<p>Eighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.</p>\n<p>Thirty-one percent reported some side effect, the most common being soreness at the injection site.</p>\n<p>About 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.</p>\n<p>Ran Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"</p>\n<p>\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158413272","content_text":"JERUSALEM, Aug 8 (Reuters) - Most people who received a third dose of Pfizer's COVID-19 vaccine felt similar or fewer side effects than they did after receiving the second shot, according to an initial survey in Israel.\nIsrael began offering the booster shots about 10 days ago to people over age 60 as part of efforts to slow the spread of the highly contagious Delta variant. That effectively turned Israel into a testing ground for a third dose before approval by the U.S. Food and Drug Administration.\nIsrael's largest healthcare provider, Clalit, said on Sunday it had administered a third dose of the Pfizer/BioNTech SE vaccine to more than 240,000 people.\nAbout 4,500 people, all of whom received the booster shot from July 30 to Aug. 1, responded to questions and were included in the survey.\nEighty-eight percent of participants in the survey said that in the days after receiving the third shot, they felt \"similar or better\" to how they felt after the second shot.\nThirty-one percent reported some side effect, the most common being soreness at the injection site.\nAbout 0.4% said they suffered from difficulty breathing, and 1% said they sought medical treatment due to one or more side effect.\nRan Balicer, Clalit's chief innovation officer, said that even though the results are \"initial and self-reported\", they allow a comparison of side effects with the second dose, and \"it turns out that in most cases they are similar or less in the booster.\"\n\"Although we do not yet have long-term research on the efficacy and safety of the third booster dose, for the personal risk management of any person aged 60 plus, these findings continue to point to the benefit of immunization now, along with careful behavior among adults and avoiding gathering in closed spaces,\" Balicer said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":214,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/898630327"}
精彩评论